Article detail · 2023 · article
Development and In Vitro Evaluation of Crizotinib-Loaded Lipid–Polymer Hybrid Nanoparticles Using Box–Behnken Design in Non-small Cell Lung Cancer
Journal
Springer Science and Business Media LLC
ISSN3765-8977
YÖKSİS
OpenAlex
Top 10%
Year2023
Citations21OpenAlex
Percentile%93.7
FWCI3.421.00 = world average
Data source split
- YÖKSİSYÖKSİS article record
- YÖKSİS venueSpringer Science and Business Media LLC
- OpenAlexOpenAlex enrichment (abstract, citations, topics)
Abstract
Abstract not compiled yet; it will appear after the DergiPark / OpenAlex queue runs.
Topics
Citations
OpenAlex cited_by_count. Not a WoS or Scopus citation count; those sources have no separate column here.
21citationsOpenAlex · cited_by_count (cache / database)
6 publications in the local catalog that cite this work (OpenAlex reference match; not the full global list).
- 2024 Recent progress in drug delivery systems for tyrosine kinase inhibitors in the treatment of lung cancerCitations 7 · OpenAlex
- 2024 Recent progress in drug delivery systems for tyrosine kinase inhibitors in the treatment of lung cancerCitations 7 · OpenAlex
- 2024 Recent progress in drug delivery systems for tyrosine kinase inhibitors in the treatment of lung cancerCitations 7 · OpenAlex
- 2024 Nintedanib and miR-29b co-loaded lipoplexes in idiopathic pulmonary fibrosis: formulation, characterization, and in vitro evaluationCitations 2 · OpenAlex
- 2024 Nintedanib and miR-29b co-loaded lipoplexes in idiopathic pulmonary fibrosis: formulation, characterization, and in vitro evaluationCitations 2 · OpenAlex
- 2024 Nintedanib and miR-29b co-loaded lipoplexes in idiopathic pulmonary fibrosis: formulation, characterization, and in vitro evaluationCitations 2 · OpenAlex